“It is not required to conduct animal studies for biosimilar development in some countries”

It was observed it was not required to conduct animal studies in the progress of developing biosimilars in some countries.

At the ‘Global Bio Conference’ at Intercontinental Coex Seoul on the 29^th, Dr. Jian Wang(Health Canada) gave a lecture on the subject of ‘Current trends and future of biosimilars.’

Dr. Wang said “The first biosimilar was approved in Europe in 2006. Later, the EMA approved...